Open access · CC-BY
via OpenAlex
Mesenchymal Stem Cell Therapy for Ischemic Tissues
Kar Wey Yong, Jane Ru Choi, Mehdi Mohammadi, Alim P. Mitha, Amir Sanati‐Nezhad, Arindom Sen
Stem Cells International · 2018 · ▲ 76 citations
Abstract
Ischemic diseases such as myocardial infarction, ischemic stroke, and critical limb ischemia are immense public health challenges. Current pharmacotherapy and surgical approaches are insufficient to completely heal ischemic diseases and are associated with a considerable risk of adverse effects. Alternatively, human mesenchymal stem cells (hMSCs) have been shown to exhibit immunomodulation, angiogenesis, and paracrine secretion of bioactive factors that can attenuate inflammation and promote tissue regeneration, making them a promising cell source for ischemic disease therapy. This review summarizes the pathogenesis of ischemic diseases, discusses the potential therapeutic effects and mechanisms of hMSCs for these diseases, and provides an overview of challenges of using hMSCs clinically for treating ischemic diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1155/2018/8179075
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Yong, K.W., Choi, J.R., Mohammadi, M., Mitha, A.P., Sanati‐Nezhad, A., & Sen, A. (2018). Mesenchymal Stem Cell Therapy for Ischemic Tissues. <em>Stem Cells International</em>. https://doi.org/10.1155/2018/8179075
Vancouver
Yong KW, Choi JR, Mohammadi M, Mitha AP, Sanati‐Nezhad A, Sen A. Mesenchymal Stem Cell Therapy for Ischemic Tissues. Stem Cells International. 2018. doi:10.1155/2018/8179075.
BibTeX
@article{kar2018Mesenc,
title = {Mesenchymal Stem Cell Therapy for Ischemic Tissues},
author = {Kar Wey Yong and Jane Ru Choi and Mehdi Mohammadi and Alim P. Mitha and Amir Sanati‐Nezhad and Arindom Sen},
journal = {Stem Cells International},
year = {2018},
doi = {10.1155/2018/8179075},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Sciences 2021
Open access · CC-BY
Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases
Cytotherapy 2011
Citation only
Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy
Cell Transplantation 2013
Open access · OA
Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives
Frontiers in Medical Science Research 2023
Open access · OA
Neuroprotective Effects of Fisetin by Fighting Neuroinflammation
Stem Cell Research & Therapy 2025
Open access · CC-BY
Advances in mesenchymal stem cell and exosome-based therapies for aging and age-related diseases
International Journal of Molecular Medicine 2023
Open access · CC-BY